CALCITONIN SECRETORY INDEX AND UNSUSPECTED NODAL DISEASE IN MEDULLARY THYROID CARCINOMA-Reference-Cited by-同舟云学术

CALCITONIN SECRETORY INDEX AND UNSUSPECTED NODAL DISEASE IN MEDULLARY THYROID CARCINOMA

Published:2018-05 Issue:5 Volume:24 Page:460-467
ISSN:1530-891X
Container-title:Endocrine Practice
language:en
Short-container-title:Endocrine Practice

Author:

Filimon Sabin,Payne Richard J.,Black Martin J.,Hier Michael P.,Mlynarek Alex M.,Forest Veronique-Isabelle,Tamilia Michael

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism

Reference32 articles.

1. Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity;Hazard,1959

2. Medullary thyroid cancer: clinical manifestations, diagnosis and staging;Tuttle,2016

3. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma;Wells,2015

4. Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma;Yip,2011

5. Treatment of advanced thyroid cancer with targeted therapies: ten years of experience;Viola,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pre-Operative Calcitonin and CEA Values May Predict the Extent of Metastases to the Lateral Neck Lymph Nodes in Patients with Medullary Thyroid Cancer;Cancers;2024-08-27

2. Serum Biochemical Markers for Medullary Thyroid Carcinoma: An Update;Cancer Management and Research;2024-04

3. Oncologic outcomes of calcitonin-negative medullary thyroid carcinoma;Frontiers in Endocrinology;2022-11-23

4. Medullary thyroid carcinoma: a narrative historical review;Expert Review of Anticancer Therapy;2022-06-22

5. Analytical Performance Evaluation of a New Calcitonin Assay;The Journal of Applied Laboratory Medicine;2022-01-05